Activation of group III metabotropic glutamate receptors attenuates rotenone toxicity on dopaminergic neurons through a microtubule-dependent mechanism.

Qian Jiang, Zhen Yan, Jian Feng
Author Information
  1. Qian Jiang: Department of Physiology and Biophysics, State University of New York, Buffalo, New York 14214, USA.

Abstract

Systemic administration of rotenone, a widely used pesticide, causes selective degeneration of nigral dopaminergic (DA) neurons and Parkinson's disease-like symptoms in animal models. Our previous study has shown that the microtubule-depolymerizing activity of rotenone plays a critical role in its selective toxicity on tyrosine hydroxylase-positive (TH+) neurons in rat embryonic midbrain neuronal cultures. Here, we show that application of group III metabotropic glutamate receptor (mGluRIII) agonists (e.g., L-AP-4) significantly reduced rotenone toxicity on midbrain TH+ neurons in culture. The protective effect of L-AP-4 was abolished by pharmacological inhibition of the microtubule-associated protein (MAP) kinase kinase (MEK) or overexpression of dominant-negative MEK1, suggesting its dependence on the MAP kinase cascade. We found that L-AP-4 induced a rapid and transient activation of the MAP kinase extracellular signal-regulated kinase (ERK) through a pathway mediated by dynamin, beta-arrestin 2, and Src. ERK activated in this manner targeted cytosolic rather than nuclear substrates. Consistent with this, L-AP-4 significantly attenuated rotenone- or colchicine-induced microtubule depolymerization in an MEK-dependent manner. Moreover, L-AP-4 decreased colchicine toxicity on TH+ neurons in an MEK-dependent manner as well. The protective effect of L-AP-4 against rotenone toxicity was occluded by the microtubule-stabilizing agent Taxol. Together, these results suggest that activation of group III metabotropic glutamate receptors attenuates the selective toxicity of rotenone on DA neurons by activating the MAP kinase pathway to stabilize microtubules. These findings may offer a novel neuroprotective approach against rotenone-induced parkinsonism.

References

  1. Science. 1999 Jan 29;283(5402):655-61 [PMID: 9924018]
  2. Neuron. 2003 Oct 9;40(2):415-25 [PMID: 14556718]
  3. Cell. 1993 Oct 8;75(1):25-36 [PMID: 8402898]
  4. Neurotoxicology. 2002 Oct;23(4-5):443-50 [PMID: 12428715]
  5. J Neurosci. 2000 Sep 1;20(17):6413-20 [PMID: 10964947]
  6. JAMA. 1999 Jan 27;281(4):341-6 [PMID: 9929087]
  7. Proc Natl Acad Sci U S A. 1988 Jun;85(12):4232-6 [PMID: 2454466]
  8. Ann N Y Acad Sci. 2003 Nov;1003:12-21 [PMID: 14684432]
  9. J Biol Chem. 2005 Oct 7;280(40):34105-12 [PMID: 16091364]
  10. Science. 1994 Aug 12;265(5174):966-70 [PMID: 8052857]
  11. J Cell Sci. 1992 Dec;103 ( Pt 4):953-64 [PMID: 1487506]
  12. J Biol Chem. 2002 Jun 21;277(25):22222-30 [PMID: 11956220]
  13. Pharmacol Ther. 2000 Dec;88(3):427-35 [PMID: 11337032]
  14. Neurobiol Dis. 1996;3(3):215-27 [PMID: 8980022]
  15. Int Rev Cytol. 2001;210:163-226 [PMID: 11580206]
  16. Br J Pharmacol. 2000 Oct;131(4):655-8 [PMID: 11030711]
  17. Adv Exp Med Biol. 2002;513:197-223 [PMID: 12575822]
  18. Trends Pharmacol Sci. 2004 Aug;25(8):413-22 [PMID: 15276710]
  19. Annu Rev Pharmacol Toxicol. 1997;37:205-37 [PMID: 9131252]
  20. Science. 2005 Apr 22;308(5721):512-7 [PMID: 15845844]
  21. Mol Pharmacol. 1995 May;47(5):890-7 [PMID: 7746277]
  22. J Neurosci. 2003 Aug 6;23(18):7218-26 [PMID: 12904482]
  23. J Biol Chem. 1995 Feb 3;270(5):2264-7 [PMID: 7530720]
  24. N Engl J Med. 1998 Oct 8;339(15):1044-53 [PMID: 9761807]
  25. EMBO J. 1991 Apr;10(4):885-92 [PMID: 1849075]
  26. Br J Pharmacol. 2004 Jan;141(1):15-22 [PMID: 14597605]
  27. J Biol Chem. 1963 Jan;238:418-31 [PMID: 14020001]
  28. J Neurosci. 2005 Jun 8;25(23):5488-501 [PMID: 15944377]
  29. Nat Rev Neurosci. 2005 Oct;6(10):787-98 [PMID: 16276355]
  30. Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2449-54 [PMID: 11226259]
  31. Trends Neurosci. 1996 Jul;19(7):267-71 [PMID: 8799968]
  32. Curr Opin Cell Biol. 2002 Aug;14(4):463-7 [PMID: 12383797]
  33. J Neurosci. 2003 Apr 15;23(8):3316-24 [PMID: 12716939]
  34. J Neurosci. 2000 Nov 1;20(21):7972-7 [PMID: 11050117]
  35. Mol Pharmacol. 2004 May;65(5):1103-10 [PMID: 15102938]
  36. Biochim Biophys Acta. 1978 Nov 1;543(4):590-4 [PMID: 568944]
  37. Nat Neurosci. 2000 Dec;3(12):1301-6 [PMID: 11100151]

Grants

  1. NS41722/NINDS NIH HHS

MeSH Term

Animals
Cells, Cultured
Dopamine
Excitatory Amino Acid Agents
Female
Mesencephalon
Microtubules
Neurons
Parkinsonian Disorders
Pregnancy
Rats
Rats, Sprague-Dawley
Receptors, Metabotropic Glutamate
Rotenone

Chemicals

Excitatory Amino Acid Agents
Receptors, Metabotropic Glutamate
metabotropic glutamate receptor 3
Rotenone
Dopamine

Word Cloud

Created with Highcharts 10.0.0rotenoneneuronstoxicityL-AP-4kinaseMAPselectiveTH+groupIIImetabotropicglutamatemannerdopaminergicDAmidbrainsignificantlyprotectiveeffectactivationERKpathwayMEK-dependentreceptorsattenuatesSystemicadministrationwidelyusedpesticidecausesdegenerationnigralParkinson'sdisease-likesymptomsanimalmodelspreviousstudyshownmicrotubule-depolymerizingactivityplayscriticalroletyrosinehydroxylase-positiveratembryonicneuronalculturesshowapplicationreceptormGluRIIIagonistsegreducedcultureabolishedpharmacologicalinhibitionmicrotubule-associatedproteinMEKoverexpressiondominant-negativeMEK1suggestingdependencecascadefoundinducedrapidtransientextracellularsignal-regulatedmediateddynaminbeta-arrestin2SrcactivatedtargetedcytosolicrathernuclearsubstratesConsistentattenuatedrotenone-colchicine-inducedmicrotubuledepolymerizationMoreoverdecreasedcolchicinewelloccludedmicrotubule-stabilizingagentTaxolTogetherresultssuggestactivatingstabilizemicrotubulesfindingsmayoffernovelneuroprotectiveapproachrotenone-inducedparkinsonismActivationmicrotubule-dependentmechanism

Similar Articles

Cited By